Chronic kidney disease (CKD) is increasingly recognized as a silent epidemic in Spain, with experts estimating that it impacts between one in ten and one in six adults. The lack of awareness about the disease is alarming, as many individuals are unaware of their renal health, particularly concerning albumin levels in urine, which could indicate early signs of CKD. As Alberto Ortiz, head of the Nephrology and Hypertension Service at the Fundación Jiménez Díaz Hospital, points out, there are currently more people suffering from CKD in Spain than there are unemployed individuals, underscoring the scale and seriousness of the issue.

The kidneys often do not exhibit noticeable symptoms until the disease has progressed significantly, making early detection challenging. This 'silent' nature of CKD contributes to its growing prevalence worldwide, with an estimated 850 million people living with it globally, and 4.6 million receiving Renal Replacement Therapy. The lack of proactive measures for early detection can lead to dire consequences for patients, making it critical for both individuals and healthcare providers to prioritize regular screening and awareness of kidney health.

The implications of this situation are profound, as CKD not only affects individual health but also poses significant burdens on healthcare systems. Educating the public about the importance of renal health and encouraging regular check-ups can potentially save lives. Continuous advocacy for better healthcare practices and funding for kidney disease awareness campaigns are essential steps toward addressing this 'silent epidemic' and reducing its impact on society.